Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sudden death in sickle cell disease

R J Liesner1, E A Vandenberghe

  • 1Department of Haematology, Central Middlesex Hospital, London, UK.

Journal of the Royal Society of Medicine
|August 1, 1993
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term tolerability, immunogenicity and efficacy of Nuwiq<sup>®</sup> (human-cl rhFVIII) in children with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients.

Journal of thrombosis and haemostasis : JTH·2008
Same author

Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.

British journal of haematology·2001
Same author

Are aberrant BCR--ABL transcripts more common than previously thought?

British journal of haematology·2001
Same author

FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group.

British journal of haematology·2000